HHS Lets Pharmacies Compound BPC-157 and Five Other Unapproved Peptides Despite FDA Scientists’ Safety Concerns

HHS will not pursue enforcement against qualifying pharmacies that compound six unapproved peptides, but the agency says the policy does not establish their safety or effectiveness.